Answers for the full spectrum of neurologic disease

The strength of our neuropathology section and practice comes from the large and diverse caseload received each year.
Our section is exposed to the full spectrum of neurological diseases, both neoplastic and the non-neoplastic.

2,700+

cases seen each year

6

subspecialized pathologists

Requesting a pathology consult

Our best practices enable expeditious, evidence-based results. Click here to learn more about Mayo Clinic Laboratories consultation request process.

Testing

PATHC | Pathology Consultation

NONCP | Neuro-Oncology Expanded Gene Panel with Rearrangement, Tumor

CMAPT | Chromosomal Microarray, Tumor, Formalin-Fixed Paraffin-Embedded

SARCP | Sarcoma Targeted Gene Fusion/Rearrangement Panel, Next-Generation Sequencing, Tumor

IDH12 | Isocitrate Dehydrogenase 1 and 2 (IDH1/IDH2) Mutation Analysis, Tumor

TERT | TERT Promoter Analysis, Tumor

GLIOF | 1p/19q Deletion in Gliomas, FISH, Tissue

MGMT | MGMT Promoter Methylation, Tumor

JCV | JC Virus Detection by In Situ Hybridization

EPC2 | Epilepsy, Autoimmune Evaluation, Spinal Fluid

EPS2 | Epilepsy, Autoimmune Evaluation, Serum

ENS2 | Encephalopathy, Autoimmune Evaluation, Serum

ENC2 | Encephalopathy, Autoimmune Evaluation, Spinal Fluid

DMS2 | Dementia, Autoimmune Evaluation, Serum

DMC2 | Dementia, Autoimmune Evaluation, Spinal Fluid